Schulte-Herbrüggen O[Author] - Search Results

Year	Number of Results
2001	1
2004	3
2005	4
2006	8
2007	9
2008	9
2009	4
2011	1
2012	4
2013	1
2016	1
2017	2
2021	2
2023	1
2024	0

1

[Changes in psychiatry and psychotherapy].

Schulte-Herbrüggen O, Gallinat J. Schulte-Herbrüggen O, et al. Psychiatr Prax. 2013 Nov;40(8):409-10. doi: 10.1055/s-0033-1349652. Epub 2013 Nov 5. Psychiatr Prax. 2013. PMID: 24194262 German. No abstract available.

2

Psychological trauma in soldiers-a challenge for the German Armed Forces (Bundeswehr).

Schulte-Herbrüggen O, Heinz A. Schulte-Herbrüggen O, et al. Dtsch Arztebl Int. 2012 Sep;109(35-36):557-8. doi: 10.3238/arztebl.2012.0557. Epub 2012 Sep 3. Dtsch Arztebl Int. 2012. PMID: 23130088 Free PMC article. No abstract available.

3

Neurotrophins: from pathophysiology to treatment in Alzheimer's disease.

Schulte-Herbrüggen O, Jockers-Scherübl MC, Hellweg R. Schulte-Herbrüggen O, et al. Curr Alzheimer Res. 2008 Feb;5(1):38-44. doi: 10.2174/156720508783884620. Curr Alzheimer Res. 2008. PMID: 18288930 Review.

4

Cannabis and psychosis.

Schulte-Herbrüggen O, Jockers-Scherübl MC. Schulte-Herbrüggen O, et al. Lancet. 2007 Nov 3;370(9598):1540. doi: 10.1016/S0140-6736(07)61654-7. Lancet. 2007. PMID: 17980729 No abstract available.

5

Nerve growth factor: the central hub in the development of allergic asthma?

Nassenstein C, Schulte-Herbrüggen O, Renz H, Braun A. Nassenstein C, et al. Among authors: schulte herbruggen o. Eur J Pharmacol. 2006 Mar 8;533(1-3):195-206. doi: 10.1016/j.ejphar.2005.12.061. Epub 2006 Feb 3. Eur J Pharmacol. 2006. PMID: 16458292 Review.

6

Neurotrophic factors--a tool for therapeutic strategies in neurological, neuropsychiatric and neuroimmunological diseases?

Schulte-Herbrüggen O, Braun A, Rochlitzer S, Jockers-Scherübl MC, Hellweg R. Schulte-Herbrüggen O, et al. Curr Med Chem. 2007;14(22):2318-29. doi: 10.2174/092986707781745578. Curr Med Chem. 2007. PMID: 17896980 Review.

7

Depressive symptoms and diabetes.

Schulte-Herbrüggen O, Bahri S, Röpke S. Schulte-Herbrüggen O, et al. JAMA. 2008 Nov 12;300(18):2115; author reply 2116. doi: 10.1001/jama.2008.564. JAMA. 2008. PMID: 19001618 No abstract available.

8

Escitalopram, problem-solving therapy, and poststroke depression.

Schulte-Herbrüggen O, Röpke S. Schulte-Herbrüggen O, et al. JAMA. 2008 Oct 15;300(15):1757; author reply 1758-9. doi: 10.1001/jama.300.15.1757-a. JAMA. 2008. PMID: 18854530 No abstract available.

9

The Affect Intolerance Scale (AIS), German version: A validation study in a student and clinical sample of patients with trauma-related disorders.

Bathe-Peters R, Priebe K, Schulte S, Meyer K, Schulte-Herbrüggen O, Ülsmann D, Bermpohl F, Schoofs N. Bathe-Peters R, et al. Among authors: schulte herbruggen o. J Behav Ther Exp Psychiatry. 2023 Dec;81:101841. doi: 10.1016/j.jbtep.2023.101841. Epub 2023 Feb 16. J Behav Ther Exp Psychiatry. 2023. PMID: 36827946

10

Predicting outcome of daycare cognitive behavioural therapy in a naturalistic sample of patients with PTSD: a machine learning approach.

Stuke H, Schoofs N, Johanssen H, Bermpohl F, Ülsmann D, Schulte-Herbrüggen O, Priebe K. Stuke H, et al. Among authors: schulte herbruggen o. Eur J Psychotraumatol. 2021 Sep 24;12(1):1958471. doi: 10.1080/20008198.2021.1958471. eCollection 2021. Eur J Psychotraumatol. 2021. PMID: 34589175 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

43 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year